Director | Zurich, CH
Paul has a strong focus on rare diseases and the effective and efficient commercialisation of orphan medications. He has been involved in the design, building, launch and post-launch optimisation of many innovative commercial organisations on a European or global scale. Paul is an expert in pharma collaborations with centres of excellence.
Bsc (Hons) Electrical Engineering